Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
---|---|---|---|---|---|---|
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 1.33 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 1.86 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 1 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 1.68 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 2.51 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 2.03 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 1.93 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 1.3 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 0.0 | BCD100427B001 | 6.11 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 0.5 | BCD100427B003 | 6.76 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 1.0 | BCD100427B007 | 8.36 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 2.0 | BCD100427B011 | 7.58 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 4.0 | BCD100427B015 | 5.1 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 8.0 | BCD100427B019 | 7.79 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 12.0 | BCD100427B023 | 6.1 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 24.0 | BCD100427B027 | 7.44 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 1.07 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 2.22 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 1.77 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 1.78 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 1.51 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 1.6 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 1.79 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol | 0.5 | BCD100427B004 | 8.61 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol | 1.0 | BCD100427B008 | 7.35 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol | 2.0 | BCD100427B012 | 7.33 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol | 4.0 | BCD100427B016 | 7.85 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol | 8.0 | BCD100427B020 | 7.52 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol | 12.0 | BCD100427B024 | 6.97 | pmol/sample |
LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol | 24.0 | BCD100427B028 | 7.73 | pmol/sample |